Diana Gonciar

Dr. Diana Gonciar


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AȘAlina Simona Șovrea
Alina Simona Șovrea
ABAdina Bianca Boșca
Adina Bianca Boșca
CMCarmen Stanca Melincovici
Carmen Stanca Melincovici
ACAnne-Marie Constantin
Anne-Marie Constantin
A(Andreea Moise-Crintea (Crintea)
Andreea Moise-Crintea (Crintea)
CCCarmen Bianca Crivii
Carmen Bianca Crivii
The tumor microenvironment is a highly dynamic accumulation of resident and infiltrating tumor cells, responsible for growth and invasion. The authors focused on the leading-edge concepts regarding the glioblastoma microenvironment. Due to the fact that the modern trend in the research and treatment of glioblastoma is represented by multiple approaches that target not only the primary tumor but also the neighboring tissue, the study of the microenvironment in the peritumoral tissue is an appealing direction for current and future therapies.

26 March 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DGDiana Gonciar
Diana Gonciar
TMTeodora Mocan
Teodora Mocan
LALucia Agoston-Coldea
Lucia Agoston-Coldea
Cardiovascular diseases are the main cause of death worldwide, a trend that will continue to grow over the next decade. The heart consists of a complex cellular network based mainly on cardiomyocytes, but also on endothelial cells, smooth muscle cells, fibroblasts, and pericytes, which closely communicate through paracrine factors and direct contact. These interactions serve as valuable targets in understanding the phenomenon of heart remodeling and regeneration. The advances in nanomedicine in the controlled delivery of active pharmacological agents are remarkable and may provide substantial contribution to the treatment of heart diseases. This review aims to summarize the main mechanisms involved in cardiac remodeling and regeneration and how they have been applied in nanomedicine.

17 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RORares Ilie Orzan
Rares Ilie Orzan
Adrian Bogdan ȚiguAdrian Bogdan Țigu
Adrian Bogdan Țigu
Vlad-Ionuț NechitaVlad-Ionuț Nechita
Vlad-Ionuț Nechita
Madalina NistorMadalina Nistor
Madalina Nistor
RARenata Agoston Agoston
Renata Agoston Agoston
ASAndrada Seicean
Andrada Seicean
Background: Cholangiocarcinoma (CCA) is a highly aggressive cancer of the bile ducts with a poor prognosis and limited diagnostic markers. This study aims to investigate the potential of miR-18a and miR-532 as biomarkers for CCA by exploring their correlations with clinical parameters and traditional tumor markers such as CA19.9, CEA, and AFP. Methods: This study involved a cohort of patients diagnosed with CCA. Serum levels of miR-18a and miR-532 were measured and analyzed in relation to various clinical parameters, including age, tumor markers, and histological features. Results: Serum levels of miR-18a and miR-532 were upregulated in patients with extrahepatic cholangiocarcinoma (eCCA) compared to healthy controls (p < 0.05). MiR-18a and miR-532 levels were correlated with each other (p = 0.011, Spearman’s rho = 0.482) but showed no significant correlation with age or traditional tumor markers (CA19.9, CEA, AFP). No significant differences in miR-18a and miR-532 levels were observed concerning tumor localization or histological grading. For predicting tumor resectability, miR-532 at a cut-off point of 2.12 showed a sensitivity of 72.73%, specificity of 81.25%, and an AUC of 71.3%, while miR-18a, at a cut-off of 1.83, had a sensitivity of 63.64%, specificity of 75%, and an AUC of 59.7%. ROC curve analysis suggested moderate diagnostic potential for miR-18a and miR-532, with AUC values of 0.64 and 0.689, respectively. Conclusions: Although miR-18a and miR-532 showed significant upregulation in eCCA patients compared to healthy controls, they did not demonstrate significant associations with key clinical parameters, limiting their effectiveness as standalone diagnostic biomarkers. Further research involving larger, multi-center cohorts and additional molecular markers is necessary to validate these findings and explore the broader diagnostic potential of miRNAs in CCA.

31 August 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
DGDiana Gonciar
Diana Gonciar
Alexandru George BerciuAlexandru George Berciu
Alexandru George Berciu
ADAlex Ede Danku
Alex Ede Danku
NLNoemi Lorenzovici
Noemi Lorenzovici
Eva DulfEva Dulf
Eva Dulf
LALucia Agoston-Coldea
Lucia Agoston-Coldea
(1) Background: Considering the increasing workload of pathologists, computer-assisted methods have the potential to come to their aid. Considering the prognostic role of myocardial fibrosis, its precise quantification is essential. Currently, the evaluation is performed semi-quantitatively by the pathologist, a method exposed to the issues of subjectivity. The present research proposes validating a semi-automatic algorithm that aims to quantify myocardial fibrosis on microscopic images. (2) Methods: Forty digital images were selected from the slide collection of The Iowa Virtual Slidebox, from which the collagen volume fraction (CVF) was calculated using two semi-automatic methods: CIELAB-MATLAB® and CIELAB-Python. These involve the use of color difference analysis, using Delta E, in a rectangular region for CIELAB-Python and a region with a random geometric shape, determined by the user’s cursor movement, for CIELAB-MATLAB®. The comparison was made between the stereological evaluation and ImageJ. (3) Results: A total of 36 images were included in the study (n = 36), demonstrating a high, statistically significant correlation between stereology and ImageJ on the one hand, and the proposed methods on the other (p < 0.001). The mean CVF determined by the two methods shows a mean bias of 1.5% compared with stereology and 0.9% compared with ImageJ. Conclusions: The combined algorithm has a superior performance compared to the proposed methods, considered individually. Despite the relatively small mean bias, the limits of agreement are quite wide, reflecting the variability of the images included in the study.

15 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DGDiana Gonciar
Diana Gonciar
Alexandru George BerciuAlexandru George Berciu
Alexandru George Berciu
Eva DulfEva Dulf
Eva Dulf
RORares Ilie Orzan
Rares Ilie Orzan
TMTeodora Mocan
Teodora Mocan
LALucia Agoston-Coldea
Lucia Agoston-Coldea
Background/Objectives: Recent advances in artificial intelligence, particularly in cardiac imaging, can potentially enhance patients’ diagnosis and prognosis and identify novel imaging markers. We propose an automated, computer-aided algorithm utilizing native cardiac computed tomography (CT) imaging to identify myocardial fibrosis. This study aims to evaluate its performance compared to CMR markers of fibrosis in a cohort of patients diagnosed with breast cancer. Methods: The study included patients diagnosed with early HER2+ breast cancer, who presented LV dysfunction (LVEF < 50%) and myocardial fibrosis detected on CMR at the time of diagnosis. The patients were also evaluated by cardiac CT, and the extracted images were processed for the implementation of the automatic, computer-assisted algorithm, which marked as fibrosis every pixel that fell within the range of 60–90 HU. The percentage of pixels with fibrosis was subsequently compared with CMR parameters. Results: A total of eight patients (n = 8) were included in the study. High positive correlations between the algorithm’s result and the ECV fraction (r = 0.59, p = 0.126) and native T1 (r = 0.6, p = 0.112) were observed, and a very high positive correlation with LGE of the LV(g) and the LV-LGE/LV mass percentage (r = 0.77, p = 0.025; r = 0.81, p = 0.015). A very high negative correlation was found with GLS (r = −0.77, p = 0.026). The algorithm presented an intraclass correlation coefficient of 1 (95% CI 0.99–1), p < 0.001. Conclusions: The present pilot study proposes a novel promising imaging marker for myocardial fibrosis, generated by an automatic algorithm based on native cardiac CT images.